AbbVie Inc.ABBVNYSE
Loading
R&D Expenses Over TimeContracting
Percentile Rank86
3Y CAGR+11.8%
5Y CAGR+3.2%
Year-over-Year Change
Research and development spending
3Y CAGR
+11.8%/yr
vs -11.8%/yr prior
5Y CAGR
+3.2%/yr
Recent acceleration
Acceleration
+23.6pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $9.10B | -28.9% |
| 2024 | $12.79B | +66.7% |
| 2023 | $7.67B | +17.9% |
| 2022 | $6.51B | -19.1% |
| 2021 | $8.05B | +3.8% |
| 2020 | $7.75B | +14.2% |
| 2019 | $6.79B | -36.8% |
| 2018 | $10.75B | +101.6% |
| 2017 | $5.33B | +16.3% |
| 2016 | $4.58B | - |